Keywords: Roche, PTC Therapeutics, SMA profram, Muscular atrophy, Galena BioPharma, Herceptin, NeuVax, Breast cancer

Roche signs up to $490 million accord with PTC Thera for SMA program; and deal with Galena

Article | 30 November 2011

Print This

Swiss drug major Roche (ROG: SIX) has signed a licensing agreement with privately-held US firm PTC Therapeutics and the SMA ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in